|
1.
|
|
7 p, 1.1 MB |
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
/
Marin-Bejar, Oskar (Institut d'Investigació Biomèdica de Bellvitge) ;
Romero-Moya, Damia (Institut d'Investigació Biomèdica de Bellvitge) ;
Rodriguez-Ubreva, Javier (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Distefano, Maximiliano (Hospital Sant Joan de Déu (Manresa)) ;
Lessi, Francesca (Fondazione Pisana Per la Scienza ONLUS (FPS)) ;
Aretini, Paolo (Fondazione Pisana Per la Scienza ONLUS (FPS)) ;
Liquori, Alessandro (Instituto de Salud Carlos III) ;
Castaño, Julio (Banc de Sang i Teixits) ;
Kozyra, Emilia (University of Freiburg) ;
Kotmayer, Lili (Semmelweis University. Budapest, Hungary) ;
Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Cervera, José (Hospital Universitari i Politècnic La Fe (València)) ;
Rodriguez-Gallego, José Carlos (University of Las Palmas de Gran Canaria) ;
Nomdedeu, Josep Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Murillo- Sanjuán, Laura (Vall d'Hebron Institut d'Oncologia) ;
de Heredia, Cristina Díaz (Vall d'Hebron Institut d'Oncologia) ;
Pérez-Martinez, Antonio (Universidad Autónoma de Madrid) ;
López-Cadenas, Félix (Instituto Biosanitario de Salamanca (IBSAL)) ;
Martínez-Laperche, Carolina (Hospital Gregorio Marañón. Instituto de Investigación Sanitaria) ;
Dorado-Herrero, Nieves (Hospital Gregorio Marañón. Instituto de Investigación Sanitaria) ;
Marco, Francisco M. (Institute for Health and Biomedical Research (ISABIAL)) ;
Prósper, Felipe (Instituto de Salud Carlos III) ;
Menendez, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ;
Ballestar, Esteban (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Bödör, Csaba (Semmelweis University. Budapest, Hungary) ;
Bigas Salvans, Anna (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Catalá, Albert (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Wlodarski, Marcin W. (St. Jude Children's Research Hospital, Memphis, TN) ;
Giorgetti, Alessandra (Institut d'Investigació Biomèdica de Bellvitge) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
2023 -  10.3324/haematol.2022.282305
Haematologica, Vol. 108 Núm. 9 (september 2023) , p. 2551-2557
|
|
|
2.
|
|
40 p, 1.1 MB |
Computational design of molecularly imprinted polymer for direct detection of melamine in milk
/
Bates, Ferdia (Universitat Autònoma de Barcelona. Departament de Química) ;
Busato, Mirko (University of Verona. Department of Biotechnology) ;
Piletska, Elena (University of Leicester. Department of Chemistry) ;
Whitcombe, Michael J. (University of Leicester. Department of Chemistry) ;
Karim, Kal (University of Leicester. Department of Chemistry) ;
Guerreiro, Antonio (University of Leicester. Department of Chemistry) ;
Valle Zafra, Manuel del (Universitat Autònoma de Barcelona. Departament de Química) ;
Giorgetti, Alejandro (University of Verona. Department of Biotechnology) ;
Piletsky, Sergey (University of Leicester. Department of Chemistry)
A novel protocol for use of molecularly imprinted polymer (MIP) in analysis of melamine is presented. Design of polymer for melamine has been achieved using a combination of computational techniques and laboratory trials, the former greatly reducing the duration of the latter. [...]
2017 - 10.1080/01496395.2017.1287197
Separation Science and Technology, Vol. 52, Issue 8 (March 2017) , p. 1441-1453
|
|
|
3.
|
|
14 p, 2.9 MB |
GATA2 deficiency and MDS/AML : Experimental strategies for disease modelling and future therapeutic prospects
/
Kotmayer, Lili (Semmelweis University) ;
Romero-Moya, Damià (Institut d'Investigació Biomèdica de Bellvitge) ;
Marin-Béjar, Oskar (Institut d'Investigació Biomèdica de Bellvitge) ;
Kozyra, Emilia (University of Freiburg) ;
Català, Albert (Hospital Sant Joan de Deu) ;
Bigas Salvans, Anna (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Wlodarski, Marcin W. (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ;
Bödör, Csaba (Semmelweis University) ;
Giorgetti, Alessandra (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental)
The importance of predisposition to leukaemia in clinical practice is being increasingly recognized. This is emphasized by the establishment of a novel WHO disease category in 2016 called "myeloid neoplasms with germline predisposition". [...]
2022 - 10.1111/bjh.18330
British Journal of Haematology, Vol. 199 Núm. 4 (november 2022) , p. 482-495
|
|
|
4.
|
|
14 p, 1.2 MB |
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis
/
Vila Cuenca, Marc (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Marchi, Giacomo (Azienda Ospedaliera Universitaria Integrata di Verona) ;
Barqué, Anna (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Esteban-Jurado, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Marchetto, Alessandro (University of Verona) ;
Giorgetti, Alejandro (Department of Biotechnology, University of Verona) ;
Chelban, Viorica (National Hospital for Neurology and Neurosurgery, London) ;
Houlden, Henry (National Hospital for Neurology and Neurosurgery, London) ;
Wood, Nicholas W.. (National Hospital for Neurology and Neurosurgery, London) ;
Piubelli, Chiara (Centre for Tropical Diseases, Ospedale Sacro Cuore - Don Calabria) ;
Dorigatti Borges, Marina (University of Campinas-UNICAMP) ;
Martins de Albuquerque, Dulcinéia (University of Campinas-UNICAMP) ;
Yotsumoto Fertrin, Kleber (University of Campinas-UNICAMP) ;
Jové-Buxeda, Ester (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Sánchez-Delgado, Jordi (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Baena Díez, Neus (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Burnyte, Birute (Vilnius University) ;
Utkus, Algirdas (Vilnius University) ;
Busti, Fabiana (Azienda Ospedaliera Universitaria Integrata di Verona) ;
Kaubrys, Gintaras (Vilnius University) ;
Suku, Eda (University of Verona) ;
Kowalczyk, Kamil (Medical University of Gdańsk) ;
Karaszewski, Bartosz (Medical University of Gdańsk) ;
Porter, John B. (University College London NHS Foundation Trust) ;
Pollard, Sally (Consultant Paediatrician, Bradford Royal Infirmary) ;
Eleftheriou, Perla (University College London NHS Foundation Trust) ;
Bignell, Patricia (Oxford University Hospitals NHS Foundation Trust) ;
Girelli, Domenico (Azienda Ospedaliera Universitaria Integrata di Verona) ;
Sánchez-Fernández, Mayka (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Aceruloplasminemia is a rare autosomal recessive genetic disease characterized by mild microcytic anemia, diabetes, retinopathy, liver disease, and progressive neurological symptoms due to iron accumulation in pancreas, retina, liver, and brain. [...]
2020 - 10.3390/ijms21072374
International journal of molecular sciences, Vol. 21 (march 2020)
|
|
|
5.
|
|
15 p, 4.2 MB |
GATA2 Promotes Hematopoietic Development and Represses Cardiac Differentiation of Human Mesoderm
/
Castaño Cardoso, Julio (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ;
Aranda, Sergi (Universitat Pompeu Fabra. Centre de Regulació Genòmica (CRG-UPF)) ;
Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Calero-Nieto, Fernando (Department of Hematology. Wellcome and MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research. University of Cambridge) ;
Mejia-Ramirez, Eva (Centro de Medicina Regenerativa de Barcelona) ;
Mosquera, José Luis (Institut d'Investigació Biomèdica de Bellvitge) ;
Blanco, Enrique (Universitat Pompeu Fabra. Centre de Regulació Genòmica (CRG-UPF)) ;
Wang, Xiaonan (Wellcome and MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research. University of Cambridge) ;
Prieto, Cristina (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Zabaleta, Lorea (Laboratory of Hematological Diseases. Fundación Inbiomed) ;
Mereu, Elisabetta (Centre de Regulació Genòmica) ;
Rovira, Meritxell (Centro de Medicina Regenerativa de Barcelona) ;
Jiménez-Delgado, Senda (Centro de Medicina Regenerativa de Barcelona) ;
Matson, Daniel Rusch (Department of Cell and Regenerative Biology. UW-Madison Blood Research Program. Carbone Cancer Center. University of Wisconsin School of Medicine and Public Health) ;
Heyn, Holger (Universitat Pompeu Fabra) ;
Bresnick, Emery H. (Department of Cell and Regenerative Biology. UW-Madison Blood Research Program. Carbone Cancer Center. University of Wisconsin School of Medicine and Public Health) ;
Göttgens, Berthold (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Di Croce, Luciano (Institució Catalana de Recerca i Estudis Avançats) ;
Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Raya, Ángel (Institució Catalana de Recerca i Estudis Avançats) ;
Giorgetti, Alessandra (Centro de Medicina Regenerativa de Barcelona) ;
Universitat Autònoma de Barcelona
In vertebrates, GATA2 is a master regulator of hematopoiesis and is expressed throughout embryo development and in adult life. Although the essential role of GATA2 in mouse hematopoiesis is well established, its involvement during early human hematopoietic development is not clear. [...]
2019 - 10.1016/j.stemcr.2019.07.009
Stem cell reports, Vol. 13 Núm. 3 (october 2019) , p. 515-529
|
|
|
6.
|
|
17 p, 3.5 MB |
Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
/
Muñoz López, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Romero Moya, Damià (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Prieto, Cristina (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Ramos Mejía, Verónica (Centro Pfizer - Universidad de Granada - Junta de Andalucía de Genómica e Investigación Oncológica) ;
Agraz-Doblás, Antonio (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Varela, Ignacio (Instituto de Biomedicina y Biotecnología de Cantabria) ;
Buschbeck, Marcus (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Palau de Miguel, Anna (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Carvajal Vergara, Xonia (Universidad de Navarra. Centro de Investigación Médica Aplicada) ;
Giorgetti, Alessandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Ford, Anthony (Institute of Cancer Research (London, Gran Bretanya)) ;
Lako, Majlinda (Newcastle University. Institute of Genetic Medicine) ;
Granada, Isabel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ruiz Xivillé, Neus (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rodríguez Perales, Sandra (Centro Nacional de Investigaciones Oncológicas) ;
Torres Ruíz, Raúl (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Stam, Ronald W. (Erasmus University Medical Center (Rotterdam, Holanda)) ;
Fuster, José Luis (Hospital Clínico Universitario Virgen de la Arrixaca (El Palmar, Múrcia)) ;
Fraga, Mario F.. (Instituto Universitario de Oncología del Principado de Asturias (Oviedo)) ;
Nakanishi, Mahito (National Institute of Advanced Industrial Science and Technology (Tsukuba, Japó)) ;
Cazzaniga, Giovanni (Università degli Studi di Milano-Bicocca) ;
Bardini, Michela (Università degli Studi di Milano-Bicocca) ;
Cobo, Isabel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Fernández Bayón, Gustavo (Instituto Universitario de Oncología del Principado de Asturias (Oviedo)) ;
Fernández, Agustín F. (Instituto Universitario de Oncología del Principado de Asturias (Oviedo)) ;
Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Induced pluripotent stem cells (iPSCs) are a powerful tool for disease modeling. They are routinely generated from healthy donors and patients from multiple cell types at different developmental stages. [...]
2016 - 10.1016/j.stemcr.2016.08.013
Stem cell reports, Vol. 7 Núm. 4 (October 2016)
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
